More than half of those with neurological and psychiatric symptoms had persistent symptoms at 23 weeks after discharge
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Feb. 3, 2022 (HealthDay News) -- Most patients with multisystem inflammatory syndrome in children (MIS-C) have new-onset neurological, psychiatric, and sleep symptoms, with many of these symptoms persisting after discharge, according to a study published online Jan. 24 in the Journal of Child Neurology.
Stephanie Enner, M.D., from Cohen Children's Medical Center in New York City, and colleagues conducted a single-center retrospective chart review and cross-sectional survey of patients diagnosed with MIS-C. Forty-seven patients and their parents were surveyed on symptoms before COVID-19, upon admission, and at 23 weeks after discharge.
The researchers found that 77, 60, and 77 percent of patients reported neurological, psychiatric, and sleep symptoms, respectively, during hospitalization. Prior to hospitalization, these symptoms were reported by 15, 0, and 7 percent, respectively. Of the 36 patients with neurological symptoms during hospitalization, 50 percent continued to have symptoms on follow-up (odds ratio,∞). Similarly, persistence was reported by 57 percent of the 28 patients with psychiatric symptoms (odds ratio, 5.00) and 42 percent of the 18 patients with sleep disturbance during hospitalization (odds ratio, 1.9). Compared with the control group, the aggregate of neurological, psychiatric, and sleep symptoms during admission and at follow-up was significantly higher for MIS-C patients requiring intensive care unit admission.
"This study highlights the neuropsychiatric and sleep changes in hospitalized children with MIS-C, and brings attention to the persistence of these symptoms after hospital discharge," the authors write.
From Your Site Articles
- Cardiac Outcomes Good for Children With COVID-19-Related MIS-C ... ›
- MIS-C Diagnosed More Often in Black, Hispanic Children ... ›
- Two Doses of BNT162b2 Vaccine Protect Against MIS-C ... ›
- MIS-C Rare in 12- to 20-Year-Olds After COVID-19 Vaccination - Consumer Health News | HealthDay ›
- SARS-CoV-2 Vaccination Seems Safe After MIS-C - Consumer Health News | HealthDay ›
- Older Kids More Vulnerable to MIS-C: Study - Consumer Health News | HealthDay ›
- Los niños mayores son más vulnerables al SIM-N, según un estudio - Consumer Health News | HealthDay ›
- Audible Smoke Alarm More Effective With Increasing Child Age - Consumer Health News | HealthDay ›
Related Articles Around the Web
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 23, 2022
Read this Next
Other Trending Articles